Expressive writing as a therapeutic process for drug-dependent women

Sarah Meshberg-Cohen, Dace Svikis, Thomas J. McMahon

Research output: Contribution to journalArticle

Abstract

Background: Although women with substance use disorders (SUDs) have high rates of trauma and posttraumatic stress, many addiction programs do not offer trauma-specific treatments. One promising intervention is Pennebaker's expressive writing, which involves daily, 20-minute writing sessions to facilitate disclosure of stressful experiences. Methods: Women (N = 149) in residential treatment completed a randomized clinical trial comparing expressive writing with control writing. Repeated-measures analysis of variance was used to document change in psychological and physical distress from baseline to 2-week and 1-month follow-ups. Analyses also examined immediate levels of negative affect following expressive writing. Results: Expressive writing participants showed greater reductions in posttraumatic symptom severity, depression, and anxiety scores, when compared with control writing participants at the 2-week follow-up. No group differences were found at the 1-month follow-up. Safety data were encouraging: although expressive writing participants showed increased negative affect immediately after each writing session, there were no differences in pre-writing negative affect scores between conditions the following day. By the final writing session, participants were able to write about traumatic/stressful events without having a spike in negative affect. Conclusions: Results suggest that expressive writing may be a brief, safe, low-cost, adjunct to SUD treatment that warrants further study as a strategy for addressing posttraumatic distress in substance-abusing women.

Original languageEnglish (US)
Pages (from-to)80-88
Number of pages9
JournalSubstance Abuse
Volume35
Issue number1
DOIs
StatePublished - Jan 1 2014
Externally publishedYes

Fingerprint

Pharmaceutical Preparations
Therapeutics
Substance-Related Disorders
Residential Treatment
Wounds and Injuries
Disclosure
Analysis of Variance
Anxiety
Randomized Controlled Trials
Depression
Psychology
Safety
Costs and Cost Analysis

Keywords

  • Expressive writing
  • substance abuse
  • trauma

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Psychiatry and Mental health

Cite this

Expressive writing as a therapeutic process for drug-dependent women. / Meshberg-Cohen, Sarah; Svikis, Dace; McMahon, Thomas J.

In: Substance Abuse, Vol. 35, No. 1, 01.01.2014, p. 80-88.

Research output: Contribution to journalArticle

Meshberg-Cohen, Sarah ; Svikis, Dace ; McMahon, Thomas J. / Expressive writing as a therapeutic process for drug-dependent women. In: Substance Abuse. 2014 ; Vol. 35, No. 1. pp. 80-88.
@article{2da698724d0644ec8ba9ee0516507605,
title = "Expressive writing as a therapeutic process for drug-dependent women",
abstract = "Background: Although women with substance use disorders (SUDs) have high rates of trauma and posttraumatic stress, many addiction programs do not offer trauma-specific treatments. One promising intervention is Pennebaker's expressive writing, which involves daily, 20-minute writing sessions to facilitate disclosure of stressful experiences. Methods: Women (N = 149) in residential treatment completed a randomized clinical trial comparing expressive writing with control writing. Repeated-measures analysis of variance was used to document change in psychological and physical distress from baseline to 2-week and 1-month follow-ups. Analyses also examined immediate levels of negative affect following expressive writing. Results: Expressive writing participants showed greater reductions in posttraumatic symptom severity, depression, and anxiety scores, when compared with control writing participants at the 2-week follow-up. No group differences were found at the 1-month follow-up. Safety data were encouraging: although expressive writing participants showed increased negative affect immediately after each writing session, there were no differences in pre-writing negative affect scores between conditions the following day. By the final writing session, participants were able to write about traumatic/stressful events without having a spike in negative affect. Conclusions: Results suggest that expressive writing may be a brief, safe, low-cost, adjunct to SUD treatment that warrants further study as a strategy for addressing posttraumatic distress in substance-abusing women.",
keywords = "Expressive writing, substance abuse, trauma",
author = "Sarah Meshberg-Cohen and Dace Svikis and McMahon, {Thomas J.}",
year = "2014",
month = "1",
day = "1",
doi = "10.1080/08897077.2013.805181",
language = "English (US)",
volume = "35",
pages = "80--88",
journal = "Substance Abuse",
issn = "0889-7077",
publisher = "Routledge",
number = "1",

}

TY - JOUR

T1 - Expressive writing as a therapeutic process for drug-dependent women

AU - Meshberg-Cohen, Sarah

AU - Svikis, Dace

AU - McMahon, Thomas J.

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Background: Although women with substance use disorders (SUDs) have high rates of trauma and posttraumatic stress, many addiction programs do not offer trauma-specific treatments. One promising intervention is Pennebaker's expressive writing, which involves daily, 20-minute writing sessions to facilitate disclosure of stressful experiences. Methods: Women (N = 149) in residential treatment completed a randomized clinical trial comparing expressive writing with control writing. Repeated-measures analysis of variance was used to document change in psychological and physical distress from baseline to 2-week and 1-month follow-ups. Analyses also examined immediate levels of negative affect following expressive writing. Results: Expressive writing participants showed greater reductions in posttraumatic symptom severity, depression, and anxiety scores, when compared with control writing participants at the 2-week follow-up. No group differences were found at the 1-month follow-up. Safety data were encouraging: although expressive writing participants showed increased negative affect immediately after each writing session, there were no differences in pre-writing negative affect scores between conditions the following day. By the final writing session, participants were able to write about traumatic/stressful events without having a spike in negative affect. Conclusions: Results suggest that expressive writing may be a brief, safe, low-cost, adjunct to SUD treatment that warrants further study as a strategy for addressing posttraumatic distress in substance-abusing women.

AB - Background: Although women with substance use disorders (SUDs) have high rates of trauma and posttraumatic stress, many addiction programs do not offer trauma-specific treatments. One promising intervention is Pennebaker's expressive writing, which involves daily, 20-minute writing sessions to facilitate disclosure of stressful experiences. Methods: Women (N = 149) in residential treatment completed a randomized clinical trial comparing expressive writing with control writing. Repeated-measures analysis of variance was used to document change in psychological and physical distress from baseline to 2-week and 1-month follow-ups. Analyses also examined immediate levels of negative affect following expressive writing. Results: Expressive writing participants showed greater reductions in posttraumatic symptom severity, depression, and anxiety scores, when compared with control writing participants at the 2-week follow-up. No group differences were found at the 1-month follow-up. Safety data were encouraging: although expressive writing participants showed increased negative affect immediately after each writing session, there were no differences in pre-writing negative affect scores between conditions the following day. By the final writing session, participants were able to write about traumatic/stressful events without having a spike in negative affect. Conclusions: Results suggest that expressive writing may be a brief, safe, low-cost, adjunct to SUD treatment that warrants further study as a strategy for addressing posttraumatic distress in substance-abusing women.

KW - Expressive writing

KW - substance abuse

KW - trauma

UR - http://www.scopus.com/inward/record.url?scp=84897714107&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84897714107&partnerID=8YFLogxK

U2 - 10.1080/08897077.2013.805181

DO - 10.1080/08897077.2013.805181

M3 - Article

C2 - 24588298

AN - SCOPUS:84897714107

VL - 35

SP - 80

EP - 88

JO - Substance Abuse

JF - Substance Abuse

SN - 0889-7077

IS - 1

ER -